|
RGIN
Nov 7, 2016 13:14:18 GMT
Post by hansgruber on Nov 7, 2016 13:14:18 GMT
This stock has potential for a quick double. Just had a pre-ind meeting with the FDA and from what i hear they will be announcing their IND approval soon. With such a small market cap i can see a nice SHORT LIVED spike when announced. I'm not as intersted in the science or long term hold here at this time but do think there will be a quick profitable flip opportunity.
Regenicin, Inc. focuses to develop and commercialize a technology of tissue-engineered skin substitutes to restore the healthy human skin qualities for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. Its development products include NovaDerm, a cultured skin substitute product for the treatment of burns...
|
|
|
RGIN
Dec 23, 2016 18:20:11 GMT
via mobile
JHam likes this
Post by hansgruber on Dec 23, 2016 18:20:11 GMT
In case anyone cares, stock up to .11. Over doubled the past month. haven't announced fda approval yet so still think there's room to move up. Again, will be selling as soon as news hits. Very lightly traded stock volume wise so not an easy entrance or exit...
|
|